No phaseRecruiting

Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment

Clinical and Biochemical Assessment of the Effectivness of Topical Coenzyme Q10 and Topical Curcumin in Managment of Oral Leukoplakia (A Randomized Controlled Clinical Trial)

Sponsor
Alexandria University (Academic or other)
Enrollment
34 planned
Conditions
Oral Leukoplakia
Interventions
Coenzyme Q10 gel; Topical curcumin gel
Ages
adults, older adults
Registry
NCT07331935

Full record on ClinicalTrials.gov

From the registry

Oral leukoplakia (OL) is recognized as the most common potentially malignant disorder of the oral mucosa. The pathogenesis of OL is complex and multifactorial, with oxidative stress playing a central role. Topical antioxidants have gained attention as therapeutic options to help stabilize lesions and potentially prevent malignant transformation. Both CoQ10 and curcumin have demonstrated a clinical success as strong antioxidants showing their capacity to reduce the lesion size and to stabilize the disease, ultimately preventing progression into oral malignancy. Aim: This study aims to clinically and biochemically assess the effectiveness of topical Coenzyme Q10 and Curcumin in the management of homogeneous oral leukoplakia.

Primary outcomes

  • Change in lesion size

History

  1. Primary completion

  2. Registered

  3. Started